NeuroQure
Overview
NeuroQure provides genetic testing and analysis services focused on neurological and neuropsychiatric conditions, enabling clinicians and patients to identify genetic risk factors and inform treatment decisions. The company leverages advanced genomic sequencing technology to deliver comprehensive, actionable insights for conditions affecting the nervous system.
More in Genetic Testing
Latest industry news
Guardant Health's FDA-Cleared Genomic-Epigenomic Liquid Biopsy Panel Reshapes the Oncology Testing Landscape
2026-10-29 · Product
CSF DNA Testing Poised to Transform Brain Tumor Diagnosis
2026-10-28 · Research
Tempus AI Wins FDA Clearance for Pulmonary Hypertension Diagnostic Tool, Expanding Its Clinical AI Footprint
2026-10-27 · Product
Vietnam's Gene Solutions Eyes Hong Kong IPO to Fuel Regional Genomics Expansion
2026-10-26 · Industry
Company details
Category
🧬 Genetic Testing
Funding
Private
Listed
2026-07-29
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →